Novo Nordisk A/S (NVO)
39.05
+0.55
(+1.43%)
USD |
NYSE |
Mar 05, 16:00
39.11
+0.06
(+0.15%)
After-Hours: 18:30
Novo Nordisk Price : 39.05 for March 5, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 237.36 |
| Evaxion AS | 3.40 |
| Regeneron Pharmaceuticals, Inc. | 764.91 |
| Viking Therapeutics, Inc. | 31.51 |
| DBV Technologies SA | 22.06 |
Price Related Metrics
| PE Ratio | 11.26 |
| PS Ratio | 3.719 |
| PEG Ratio | 1.994 |
| Price to Book Value | 7.503 |
| Price to Free Cash Flow | 39.49 |
| Earnings Yield | 8.88% |
| Market Cap | 173.57B |
| PEGY Ratio | 1.111 |
| Operating PE Ratio | 9.032 |
| Normalized PE Ratio | 11.26 |